APA (7th ed.) Citation

M, C. N., S, A., IC, T., P, G., E, F., MK, T., & ME, M. (2025). Safety and Effectiveness of Nirmatrelvir-Ritonavir in Patients With Advanced Kidney Dysfunction and COVID-19. American journal of kidney diseases : the official journal of the National Kidney Foundation, 86(2), 202. https://doi.org/10.1053/j.ajkd.2025.02.603

Chicago Style (17th ed.) Citation

M, Contreras Nieves, Anand S, Thomas IC, Geldsetzer P, Fung E, Tamura MK, and Montez-Rath ME. "Safety and Effectiveness of Nirmatrelvir-Ritonavir in Patients With Advanced Kidney Dysfunction and COVID-19." American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation 86, no. 2 (2025): 202. https://doi.org/10.1053/j.ajkd.2025.02.603.

MLA (9th ed.) Citation

M, Contreras Nieves, et al. "Safety and Effectiveness of Nirmatrelvir-Ritonavir in Patients With Advanced Kidney Dysfunction and COVID-19." American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation, vol. 86, no. 2, 2025, p. 202, https://doi.org/10.1053/j.ajkd.2025.02.603.